107 Wenhua Xi Road, Jinan, Shandong, 250012, China
Phase 1 Clinical Trial Center, Qilu Hospital of Shandong University; NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, China
Xiaoyan Liu is an associate professor working in Phase 1 Clinical Trial Center, Qilu Hospital of Shandong University, Jinan, P.R.China. Since 2006, she has performed research in the field of phase 1 clinical trial for more than 20 drugs and has accumulated extensive experience in protocol design, assay validation and protocol implementation. In 2018, she obtained her PhD degree in Leiden University Medical Center with her interesting on the personalized medicine in oncology. Xiaoyan Liu has published more than 20 articles in the international peer reviewed scientific journals, such as Clinical Cancer Research, Frontiers in Oncology, European Journal of Clinical Pharmacology, etc. She is the program leader of grant 81902585 supported by National Natural Science Foundation of China, and also participated in a number of grants funded by National Natural Science Foundation of China and Natural Science Foundation of Shandong Province. She has held a number of national offices at scientific organizations. She is the youth committee member of Drug Metabolism Division of Chinese Pharmacological Society; committee member of Therapeutic Drug Monitoring Division of Shandong Pharmacological Society.